bezafibrate has been researched along with enalapril in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Gagnon, C; Garcia-Ac, A; Sauvé, S; Segura, PA | 1 |
Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K | 1 |
Gagnon, C; Garcia-Ac, A; Sauvé, S; Segura, PA; Viglino, L | 1 |
4 other study(ies) available for bezafibrate and enalapril
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Determination of bezafibrate, methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters using on-line solid-phase extraction liquid chromatography coupled to polarity-switching electrospray tandem mass spectrometry.
Topics: Bezafibrate; Chromatography, Liquid; Cyclophosphamide; Enalapril; Environmental Monitoring; Lactones; Methotrexate; Orlistat; Solid Phase Extraction; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical; Water Purification; Water Supply | 2009 |
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan | 2009 |
Comparison of APPI, APCI and ESI for the LC-MS/MS analysis of bezafibrate, cyclophosphamide, enalapril, methotrexate and orlistat in municipal wastewater.
Topics: Bezafibrate; Chromatography, Liquid; Cyclophosphamide; Enalapril; Flow Injection Analysis; Lactones; Mass Spectrometry; Methotrexate; Orlistat; Sewage; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical | 2011 |